Rare Disease Week2023-03-30T14:15:28-04:00

Advocacy Tips from Batten Families

Watch the video below for takeaways from BDSRA staff and a board member regarding Rare Disease Day events.

BDSRA Marketing & PR Coordinator Patrick Kotnik met with two staffers representing Ohio legislators. Watch his summary below!

COLUMN: Rare Disease Week offers a storybook ending and road for optimism

We were witnesses to a storybook ending on a day dedicated to raising awareness and educating others on Rare Disease Day.

Ron Bartek, the Co-Founder and President of Friedreich’s Ataxia Research Alliance (FARA), received word shortly before Rare Disease Day at NIH wrapped up that the FDA approved the first-ever drug for Friedreich’s Ataxia (a rare inherited disease that causes progressive damage to your nervous system and movement problems) called SKYCLARYS for the treatment of people 16 years or older.

Relief, emotion, and catharsis consumed Bartek, who lost his son, Keith, at age 24 due to heart failure from Friedreich’s Ataxia.

Click here to read more

Interested in Advocating?

Feel free to share this BDSRA one-pager in your meetings with state and local representatives!

Go to Top